"If you're a start-up company you're going to live by the FDA and die by the FDA."

— Omar Latouff, MD, founder of TransCardiac Therapeutics, during a panel discussion at the SEMDA annual meeting, "CEO's newest challenge: Cost of growth or growth of costs."

No Comments